Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 18864 [2019-08997]
Download as PDF
18864
Federal Register / Vol. 84, No. 85 / Thursday, May 2, 2019 / Notices
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), National
Shipbuilding Research Program
(‘‘NSRP’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Vigor Marine LLC, Seattle,
WA, has been added as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NSRP intends
to file additional written notifications
disclosing all changes in membership.
On March 13, 1998, NSRP filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on January 29, 1999 (64 FR 4708).
The last notification was filed with
the Department on January 16, 2019. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on February 12, 2019 (84 FR 3492).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–08995 Filed 5–1–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
khammond on DSKBBV9HB2PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on April
8, 2019, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Medical Technology
Enterprise Consortium (‘‘MTEC’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Securisyn Medical, LLC,
Highlands Ranch, CO; Polaris Alpha
Advanced Systems, Inc., Aberdeen
Proving Ground, MD; Arrevus, Inc.,
VerDate Sep<11>2014
18:51 May 01, 2019
Jkt 247001
Raleigh, NC; Initiate Government
Solutions, LLC, North Palm Beach, FL;
7–SIGMA Incorporated, Minneapolis,
MN; MAE Group, Deerfield, NH; Radical
Concepts LLC, Brooklyn, NY; Next
Generation Stretcher Ltd, Raman gan,
Israel; Pop Test Oncology LLC aka
Palisades Therapeutics, Cliffside Park,
NJ; George Mason University, Manassas,
VA; Phagelux (Canada) Inc., Montre´al,
CANADA; MY01 Inc., Montreal,
CANADA; MilanaPharm, LLC,
Tallassee, AL; Leidos, Inc., Reston, VA;
InfraScan, Inc., Philadelphia, PA;
NuShores Biosciences LLC, Little Rock,
AR; Seran Bioscience, Bend, OR;
Celularity, Warren, NJ; Droper Med
America, LLC, Elgin, SC; tesa Labtec
GmbH, Langenfeld, GERMANY; Bio
Med Sciences, Inc., Allentown, PA;
Uluru Inc., Addison, TX; Trailhead
Biosystems Inc., Cleveland, OH; 410
Medical, Inc., Durham, NC; Knowledge
Driven LLC, Alexandria, VA; Arsenal
Medical, Inc., Watertown, MA;
University of North Carolina, Institute
for Trauma Recovery, Chapel Hill, NC;
Prep Tech, LLC, Westlake, LA; 21
MedTech, LLC, Burlington, NC;
Integrum Scientific, LLC, Greensboro,
NC; HYPR Life Sciences, Inc., Pilot
Mountain, NC; X-Therma Inc.,
Richmond, CA; VoluMetrix LLC,
Nashville, TN; Howmedica Osteonics
Corp. dba Stryker Orthopaedics,
Mahwah, NJ; NeuEsse Inc., Dunbar, PA;
The Geneva Foundation, Tacoma, WA;
Scinus Cell Expansion B.V., Bilthoven,
THE NETHERLANDS; Akron
Biotechnology, LLC, Boca Raton, FL;
RoosterBio Inc., Frederick, MD;
Aptitude Medical Systems, Santa
Barbara, CA; Rho Federal Systems
Division, Inc. (RhoFED), Chapel Hill,
NC; HeadsafelP Pty Ltd Bronte,
AUSTRALIA; Truecath Inc., Camarillo,
CA; Solutions Through Innovative
Technologies, Inc., Fairborn, OH;
Sempulse, LLC, San Marcos, TX; The
Curators of the University of Missouri
on behalf of the University of MissouriKansas City, Kansas City, MO; Cognitive
Medical Systems, Inc., San Diego, CA;
Hemoclear B.V., Zwolle,
NETHERLANDS; Immunexpress Inc.,
Seattle, WA; Klox Technologies, Inc.,
Laval, CANADA; Opticyte, Inc., Seattle,
WA; Physcient, Inc., Durham, NC;
ActiBioMotion, LLC, Coralville, IA;
Detact Diagnostics BV, Gronigen, THE
NETHERLANDS; SurgiBox Inc.,
Brookline, MA; Cincinnati Automation
& Mechatronics, LLC, Beavercreek, OH;
and Molecular Biologicals, Pasadena,
TX; have been added as parties to this
venture.
Also, Tallinn University of
Technology, Tallin, Estonia; National
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
Trauma Institute dba Coalition for
National Trauma Research, Marietta,
TX; East Carolina University,
Greenville, NC; EyeSonix LLC, Long
Beach, CA; ElMindA Ltd., Herzliya,
ISRAEL; Propagenix Inc., Rockville,
MD; Studio Kinection, Inc. dba
Kinection, Napa, CA; The Ohio State
University, Columbus, OH; Elemance,
LLC, Clemmons, NC; J. Craig Venter
Institute (JCVI), Rockville, MD;
LambdaVision Incorporated,
Farmington, CT; Michigan State
University, East Lansing, MI; Corvid
Technologies, Mooresville, NC; Spire,
San Francisco, CA; United Solutions,
LLC, Rockville, MD; Aleo BME, Inc.,
State College, PA; Cell Guidance
Systems Ltd, Cambridge, UK; Cole
Engineering Services, Inc., Orlando, FL;
FlexDex, Inc., Brighton, MI; Fortuna Fix,
London, UK; Hypatia Project, Reston,
VA; and MiMedx Group Inc., Marietta,
GA; have withdrawn as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014 MTEC filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 9, 2014 (79 FR 32999).
The last notification was filed with
the Department on January 28, 2019. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on February 28, 2019 (84 FR 6824).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2019–08997 Filed 5–1–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Pistoia Alliance, Inc.
Notice is hereby given that, on April
8, 2019, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Pistoia Alliance, Inc.
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
E:\FR\FM\02MYN1.SGM
02MYN1
Agencies
[Federal Register Volume 84, Number 85 (Thursday, May 2, 2019)]
[Notices]
[Page 18864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08997]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on April 8, 2019, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise
Consortium (``MTEC'') has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Securisyn Medical, LLC, Highlands Ranch, CO; Polaris
Alpha Advanced Systems, Inc., Aberdeen Proving Ground, MD; Arrevus,
Inc., Raleigh, NC; Initiate Government Solutions, LLC, North Palm
Beach, FL; 7-SIGMA Incorporated, Minneapolis, MN; MAE Group, Deerfield,
NH; Radical Concepts LLC, Brooklyn, NY; Next Generation Stretcher Ltd,
Raman gan, Israel; Pop Test Oncology LLC aka Palisades Therapeutics,
Cliffside Park, NJ; George Mason University, Manassas, VA; Phagelux
(Canada) Inc., Montr[eacute]al, CANADA; MY01 Inc., Montreal, CANADA;
MilanaPharm, LLC, Tallassee, AL; Leidos, Inc., Reston, VA; InfraScan,
Inc., Philadelphia, PA; NuShores Biosciences LLC, Little Rock, AR;
Seran Bioscience, Bend, OR; Celularity, Warren, NJ; Droper Med America,
LLC, Elgin, SC; tesa Labtec GmbH, Langenfeld, GERMANY; Bio Med
Sciences, Inc., Allentown, PA; Uluru Inc., Addison, TX; Trailhead
Biosystems Inc., Cleveland, OH; 410 Medical, Inc., Durham, NC;
Knowledge Driven LLC, Alexandria, VA; Arsenal Medical, Inc., Watertown,
MA; University of North Carolina, Institute for Trauma Recovery, Chapel
Hill, NC; Prep Tech, LLC, Westlake, LA; 21 MedTech, LLC, Burlington,
NC; Integrum Scientific, LLC, Greensboro, NC; HYPR Life Sciences, Inc.,
Pilot Mountain, NC; X-Therma Inc., Richmond, CA; VoluMetrix LLC,
Nashville, TN; Howmedica Osteonics Corp. dba Stryker Orthopaedics,
Mahwah, NJ; NeuEsse Inc., Dunbar, PA; The Geneva Foundation, Tacoma,
WA; Scinus Cell Expansion B.V., Bilthoven, THE NETHERLANDS; Akron
Biotechnology, LLC, Boca Raton, FL; RoosterBio Inc., Frederick, MD;
Aptitude Medical Systems, Santa Barbara, CA; Rho Federal Systems
Division, Inc. (RhoFED), Chapel Hill, NC; HeadsafelP Pty Ltd Bronte,
AUSTRALIA; Truecath Inc., Camarillo, CA; Solutions Through Innovative
Technologies, Inc., Fairborn, OH; Sempulse, LLC, San Marcos, TX; The
Curators of the University of Missouri on behalf of the University of
Missouri-Kansas City, Kansas City, MO; Cognitive Medical Systems, Inc.,
San Diego, CA; Hemoclear B.V., Zwolle, NETHERLANDS; Immunexpress Inc.,
Seattle, WA; Klox Technologies, Inc., Laval, CANADA; Opticyte, Inc.,
Seattle, WA; Physcient, Inc., Durham, NC; ActiBioMotion, LLC,
Coralville, IA; Detact Diagnostics BV, Gronigen, THE NETHERLANDS;
SurgiBox Inc., Brookline, MA; Cincinnati Automation & Mechatronics,
LLC, Beavercreek, OH; and Molecular Biologicals, Pasadena, TX; have
been added as parties to this venture.
Also, Tallinn University of Technology, Tallin, Estonia; National
Trauma Institute dba Coalition for National Trauma Research, Marietta,
TX; East Carolina University, Greenville, NC; EyeSonix LLC, Long Beach,
CA; ElMindA Ltd., Herzliya, ISRAEL; Propagenix Inc., Rockville, MD;
Studio Kinection, Inc. dba Kinection, Napa, CA; The Ohio State
University, Columbus, OH; Elemance, LLC, Clemmons, NC; J. Craig Venter
Institute (JCVI), Rockville, MD; LambdaVision Incorporated, Farmington,
CT; Michigan State University, East Lansing, MI; Corvid Technologies,
Mooresville, NC; Spire, San Francisco, CA; United Solutions, LLC,
Rockville, MD; Aleo BME, Inc., State College, PA; Cell Guidance Systems
Ltd, Cambridge, UK; Cole Engineering Services, Inc., Orlando, FL;
FlexDex, Inc., Brighton, MI; Fortuna Fix, London, UK; Hypatia Project,
Reston, VA; and MiMedx Group Inc., Marietta, GA; have withdrawn as
parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014 MTEC filed its original notification pursuant to
Section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to Section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on January 28,
2019. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on February 28, 2019 (84 FR 6824).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-08997 Filed 5-1-19; 8:45 am]
BILLING CODE 4410-11-P